Home
About
Overview
Sharing Data
ORCID
Help
History (13)
Outcomes of Allogeneic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for Relapsed or Refractory Acute Lymphoblastic Leukemia.
The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study.
Ezh2 Represses Transcription of Innate Lymphoid Genes in B Lymphocyte Progenitors and Maintains the B-2 Cell Fate.
The utility of aminoglycosides in an era of emerging drug resistance.
PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism.
PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism. Nature. 2021 06; 594(7862):271-276.
View in:
PubMed
subject areas
Animals
Animals, Newborn
Class I Phosphatidylinositol 3-Kinases
Disease Models, Animal
Endothelial Cells
Gain of Function Mutation
Hemangioma, Cavernous, Central Nervous System
Humans
Kruppel-Like Transcription Factors
Loss of Function Mutation
Male
MAP Kinase Kinase Kinase 3
Mechanistic Target of Rapamycin Complex 1
Mice
Mutation
Neoplasms
Sirolimus
TOR Serine-Threonine Kinases
authors with profiles
Issam Awad
Robert Shenkar
Romuald Girard